Author Archives for UroLift

Teleflex Announces Urology Times Article Highlighting the UroLift System as Providing a Superior Patient Experience for Treating Enlarged Prostate

September 16, 2019 7:46 am by UroLift

Minimally Invasive Treatment Options for BPH Remain Critical Due to Shortcomings of Surgery and Medication WAYNE, Pa. –Sept. 16, 2019... Read More

Teleflex Announces Publication of a Large Real-World Study Confirming Results from Controlled Clinical Studies of the UroLift® System

July 18, 2019 3:10 am by UroLift

Results from Multi-Center Study Support the Application of Minimally Invasive Treatment for Broader BPH Population WAYNE, Pa. – July... Read More

Teleflex announces Presentations about its UroLift® System treatment at the annual British Association of Urologists (BAUS) meeting

July 12, 2019 9:13 am by UroLift

The UroLift® System for the treatment of Benign Prostatic Hyperplasia (BPH) was the subject of three presentations at the Glasgow,... Read More

12-Month Results from Study of NeoTract’s UroLift® System for BPH in Men with an Obstructive Median Lobe Published in Prostate Cancer and Prostatic Diseases

January 8, 2019 5:58 am by UroLift

PLEASANTON, Calif. – December 14, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet... Read More

NeoTract Welcomes UK Government Announcement to Remove Barriers to Adoption of the UroLift® System for BPH Care for Every NHS Hospital in England

October 24, 2018 2:50 am by UroLift

A new Government scheme announced today selects the UroLift® System as one of seven innovations across all specialisms that are... Read More

NeoTract Announces Independent Analysis in UK Confirming Cost Effectiveness of UroLift® System Treatment for Benign Prostatic Hyperplasia (BPH)

June 7, 2018 12:35 pm by UroLift

WAYNE, PA – June 08, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet... Read More

NeoTract To Unveil New Clinical Data on the UroLift® System at American Urological Association 2018 Meeting

May 17, 2018 1:20 am by UroLift

PLEASANTON, Calif. – May 16, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet... Read More

NeoTract Inc. Announces Positive Five-Year Results for Minimally Invasive UroLift® System at American Urological Association 2017 Meeting

May 18, 2017 11:54 am by UroLift

PLEASANTON, Calif. and Boston – May 15, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs... Read More

NeoTract’s Minimally Invasive UroLift® System for Enlarged Prostate Now Shown to be Durable Through Five Years: Results from Pivotal L.I.F.T. Randomized Study Presented

March 27, 2017 8:00 am by UroLift

PLEASANTON, Calif. and LONDON – March 27, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs... Read More

Revolutionary UroLift® System launches in Ireland

March 23, 2017 8:00 am by UroLift

PLEASANTON, CA, US March 23, 2017 – NeoTract, Inc., announced today that the largest private health insurer in Ireland, Vhi... Read More

1 2 3 … 5 Next »